Safety of bivalirudin in patients with coronary artery disease.
about
Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-AnalysisA novel stearic acid-modified hirudin peptidomimetic with improved pharmacokinetic properties and anticoagulant activity.Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies.Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR).
P2860
Safety of bivalirudin in patients with coronary artery disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety of bivalirudin in patients with coronary artery disease.
@ast
Safety of bivalirudin in patients with coronary artery disease.
@en
type
label
Safety of bivalirudin in patients with coronary artery disease.
@ast
Safety of bivalirudin in patients with coronary artery disease.
@en
prefLabel
Safety of bivalirudin in patients with coronary artery disease.
@ast
Safety of bivalirudin in patients with coronary artery disease.
@en
P2860
P1476
Safety of bivalirudin in patients with coronary artery disease
@en
P2093
Gert Richardt
P2860
P304
P356
10.1517/14740338.2012.628312
P407
P577
2011-10-17T00:00:00Z